Changes in count and function of splenic lymphocytes from patients with portal hypertension

World Journal of Gastroenterology

Volumn 14, Issue 15, 2008, Pages 2377-2382

  Li, Zong Fang ^a   Zhang, Shu ^a   Lv, Gao Bo ^a   Huang, Ying ^a   Zhang, Wei ^a   Ren, Song ^a   Yang, Jun ^a   Dang, Shuang Suo ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Immune function; Lymphocyte; Portal hypertension; Spleen

Indexed keywords

ADULT; ARTICLE; B LYMPHOCYTE; CELL DENSITY; CELL ISOLATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERSPLENISM; IMMUNE STATUS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; PORTAL HYPERTENSION; QUANTITATIVE ANALYSIS; SPLEEN CELL; SPLEEN FUNCTION; SPLEEN RUPTURE; SPLEEN WEIGHT; T LYMPHOCYTE;

EID: 45849149615     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.2377     Document Type: Article

References (30)

1. Blum KS, Pabst R. Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs? Immunol Lett 2007; 108: 45-51
2. Millington OR, Zinselmeyer BH, Brewer JM, Garside P, Rush CM. Lymphocyte tracking and interactions in secondary lymphoid organs. Inflamm Res 2007; 56: 391-401
3. Armas OA, Astarita RW, Wolf PL, Moossa AR, Scott MH, Haghighi P, Lee S. Effects of cyclosporin A on the splenic tissue of rats: a histomorphometric analysis. Exp Mol Pathol 1989; 50: 92-103
4. Cesta MF. Normal structure, function, and histology of the spleen. Toxicol Pathol 2006; 34: 455-465
5. Lopes-Carvalho T, Foote J, Kearney JF. Marginal zone B cells in lymphocyte activation and regulation. Curr Opin Immunol 2005; 17: 244-250
6. Li ZF, Zhang S. The progress and prospect of fundamental research of the spleen. Xi'an liaotong Daxue Xuebao 2008; 29: 1-6
7. Wang Q. Debates on preservation or resection of portal hypertensive spleen. J Surg Concepts Pract 2007; 12: 114-115
8. Yan F, Li Z, Zhang S, Yang J, Li A, Liu X. Isolation and purification of macrophages from human spleen. Xi'an liaotong Daxue Xuebao 2004; 25: 513-516
9. Yongxiang W, Zongfang L, Guowei L, Zongzheng J, Xi C, Tao W. Effects of splenomegaly and splenic macrophage activity in hypersplenism due to cirrhosis. Am J Med 2002; 113: 428-431
10. Zhang Y, Li ZF, Sun XL, Wang JX, Su QH, Liu XG. Splenic macrophage phagocytosis and hypersplenism in cirrhotic portal hypertensive patients. Zhonghua Putong Waike Zazhi 2005; 20: 115-116
11. Peck-Radosavljevic M. Hypersplenism. Eur J Gastroenterol Hepatol 2001; 13: 317-323
12. Kraus MD. Splenic histology and histopathology: an update. Semin Diagn Pathol 2003; 20: 84-93
13. Shi BM, Wang XY, Mu QL, Wu TH, Xu J. Value of portal hemodynan-dcs and hypersplenism in cirrhosis staging. World J Gastroenterol 2005; 11: 708-711
14. Zhang L, Huo JS, Zhang HW, Chen RF, Zhang J, Mapudengo O, Fang TL, Chen Yj, Ou QJ, Chen JS. A 26-year clinical observation of splenic auto-transplantation and oesophageal transection anastomosis: a new treatment strategy in patients with portal hypertension. Chin Med J (Engl) 2007; 120:452-457
15. Jiang HC, Zhao XQ. The effect of splenectomy on cirrhosis in portal hypertension: beneficial or harmful? Zhonghua Gandan Waike Zazhi 2006; 12: 581-583
16. Yang Y, Tung JW, Ghosn EE, Herzenberg LA, Herzenberg LA. Division and differentiation of natural antibody-producing cells in mouse spleen. Proc Natl Acad Sci USA 2007; 104: 4542-4546
17. Withers DR, Kim MY, Bekiaris V, Rossi SW, Jenkinson WE, Gaspal F, McConnell F, Caamano JH, Anderson G, Lane PJ. The role of lymphoid tissue inducer cells in splenic white pulp development. Eur J Immunol 2007; 37:3240-3245
18. Muefler SN, Hosiawa-Meagher KA, Konieczny BT, Sullivan BM, Bachmann W, Locksley RM, Ahmed R, Matloubian M. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 2007; 317:670-674
19. Gong FL. Medical Immunology. Beijing- Science Press, 2000: 253-257
20. Wang Q, Zhang RD, Xdong SG, Yao M, Zhang JB, Yang YK. T, B lymphocytes and macrophages in splenomegaly of portal hypertension: an immunohistological and morphometric analysis. J Bengbu Med Coll 1992; 17:126-130
21. Shi B, Yang Z. Vascular lesion and its mechanisms in spleen under statement of portal hypertension. Zhonghua Yixue Zazhi 2000; 80:196-198
22. Kelman Z. PCNA: structure, functions and interactions. Oncogene 1997; 14: 629-640
23. Baserga R. Growth regulation of the PCNA gene. J Cell Sci 1991; 98 (Pt 4): 433-436
24. Zhu XL, Chen AF, Lin ZB. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in inummosuppressed mice. J Ethnopharmacol 2007; 111: 219-226
25. Kesteman N, Vansanten G, Pajak B, Goyert SM, Moser M. Injection of lipopolysaccharide induces the migration of splenic neutrophils to the T cell area of the white pulp: role of CD14 and OXC chemokines. J Leukoc Biol 2008; 83: 640-647
26. Freitas A, Chen J. Introduction: regulation of lymphocyte homeostasis. Microbes Infect 2002; 4:529-530
27. Li ZF, Zhang Y, Gao J, Zhang PJ, Wang JX, Liu XG. Expression and significance of Toll-like receptor 4 of splenic macrophage in patients with hypersplenism due to portal hypertension. Zhonghua Yixue Zazhi 2004; 84:1088-1091
28. Wang Q, Xia S, Jiang H. The mechanism for splenic promoting effects on liver cirrhosis. Zhonghua Yixue Zazhi 1995; 75: 594-598, 638
29. Bertoletti A, Maird MK. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Microbiol 2000; 3: 387-392
30. Jiang HC, Dai WJ, Hu Z. Problems related to spleen preservation in portal hypertension. J Surg Concepts Pract 2006; 11:193-195